曼诺斯受体向曼诺斯受体的曼诺斯连接体
Marija Paurević1, Martina Šrajer Gajdošik1, Rosana Ribić2
1Department of Chemistry, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia.
International journal of molecular sciences
|February 10, 2024
概括
曼诺糖受体 (MR) 向药物递送利用曼诺糖化配方有效地递送到免疫细胞. 这种方法显示出通过利用MR来治疗癌症和传染病的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 药物运输 药物运输 药物运输
- 生物化学 生化学
背景情况:
- 曼诺酶受体 (MR,CD 206) 是巨细胞和树突细胞上的一种内细胞受体.
- 在内分细胞分裂,抗原处理和呈现过程中,MR起着关键作用.
- MR的碳水化合物识别域 (CRD) 强烈地与寡糖结合.
研究的目的:
- 审查用于MR介导输送的曼诺基化生物活性配方的合成和应用.
- 突出了对MR连接体结合的结构特征的最新发现.
- 讨论针对癌症和传染病治疗的MR向传递.
主要方法:
- 关于曼诺化配方和MR相互作用的最新文献的综述.
- 对含有曼诺斯的配体的合成策略的分析.
- 在癌症和传染病中对治疗应用的评估.
主要成果:
- 在各种模板 (,聚合物等) 上呈现多价值的曼诺斯. 能够实现高效的MR中介交付.
- 曼诺酶配体的特定结构特征对于成功的MR结合至关重要.
- 曼诺基化配方显示出对癌症和传染病的治疗潜力.
结论:
- 曼诺基化生物活性配方对于MR向性输送是有效的.
- 了解连接体结构-结合关系是优化输送系统的关键.
- 通过MR介导的分娩为治疗各种疾病提供了一个有前途的策略.
相关概念视频
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Receptor-mediated Endocytosis
104.5K
Overview
104.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K


